Effects of halofuginone on fibrosis formation secondary to experimentally induced subglottic trauma

Laryngoscope

Volumn 117, Issue 2, 2007, Pages 299-302

  Ertuǧrul, E Eylem ^a   Cincik, Hakan ^a   Dogru, Salim ^a   Cekin, Engin ^a   Berber, Ufuk ^a   Gungor, Atila ^a   Poyrazoǧlu, I Ethem ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Fibrosis; Halofuginone; Stenosis; Subglottic injury

Indexed keywords

HALOFUGINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPITHELIZATION; FEMALE; FIBROSIS; HISTOPATHOLOGY; INFLAMMATION; INJECTION; LARYNX; LARYNX INJURY; LARYNX MUCOSA; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; STANDARDIZATION; TISSUE NECROSIS;

EID: 33846833969     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000250593.19282.47     Document Type: Article

References (15)

1. Rahbar R, Shapshay SM, Healy GB. Mitomycin: effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol 2001;110:1-6.
2. Shapshay SM, Beamis JF, Hybels RL, Bohigian RK. Endoscopic treatment of subglottic and tracheal stenosis by radial laser incision and dilation. Ann Otol Rhinol Laryngol 1987;96:661-664.
3. Catlin F, Smith R. Acquired Subglottic Stenosis. Ann Otol Rhinol Laryngol 1987;96:489-492.
4. Cincik H, Gungor A, Cakmak A, et al. The effects of mitomycin c and 5-fluorouracil/triamcinolone on fibrosis/scar tissue formation secondary to subglottic trauma. Am J Otolaryngol 2005;26:45-50.
5. Pines M, Nagler A. Halofuginone: a novel antifibrotic therapy. Gen Pharmacol 1998;30:445-450.
6. Nagler A, Rivkind AI, Raphael J, et al. Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative formation of abdominal adhesions. Ann Surg 1998;227:575-582.
7. Nyska M, Nyska A, Rivlin E, et al. Topically applied halofuginone, an inhibitor of collagen type I transcription, reduces peritendinous fibrous adhesions following surgery. Connect Tissue Res 1996;34:97-103.
8. Özçelik MF, Pekmezci S, Saribeyoǧlu K, et al. The effect of halofuginone, a specific inhibitor of collagen type I synthesis, in the prevention of esophageal strictures related to caustic injury. Am J Surg 2004;187:257-260.
9. Hawkins DB. Pathogenesis of subglottic stenosis from endotracheal intubation. Ann Otol Rhinol Laryngol 1987;96:116-117.
10. Eliashar R, Eliachar I, Esclamado R, et al. Can topical mitomycin prevent laryngotracheal stenosis? Laryngoscope 1999;109:1594-1600.
11. Gungor A, Poyrazoglu E, Cincik H, et al. the effectiveness of hyperbaric oxygen treatment in tracheal reconstruction with auricular cartilage grafts. Am J Otolaryngol 2003;24:390-394.
12. Pines M, Snyder D, Yarkoni S, Nagler A. Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. Biol Blood Marrow Transplant 2003;9:417-425.
13. Nagler A, Firman N, Feferman R, et al. Reduction in pulmonary fibrosis in vivo by halofuginone. Am J Respir Crit Care Med 1996;154:1082-1086.
14. Jaidane M, Ali-El-Dein B, Ounaies A, et al. The use of halofuginone in limiting urethral stricture formation and recurrence: an experimental study in rabbits. J Urol 2003;170:2049-2052.
15. Eliashar R, Ochana M, Maly B, et al. Halofuginone prevents subglottic stenosis in a canine model. Ann Otol Rhinol Laryngol 2006;115:382-386.